142 related articles for article (PubMed ID: 34458117)
1. Variables that Influence Platelet Function Analyzer-100™ Closure Times in Healthy Algerian Adults.
Belkacemi M; Merad Y
Int J Appl Basic Med Res; 2021; 11(3):154-159. PubMed ID: 34458117
[TBL] [Abstract][Full Text] [Related]
2. Platelet Dysfunction in Blood Donors Detected by Platelet Function Analyzer PFA-100™.
Belkacemi M; Berber A
Cureus; 2022 May; 14(5):e25497. PubMed ID: 35783880
[TBL] [Abstract][Full Text] [Related]
3. Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals.
Haubelt H; Anders C; Vogt A; Hoerdt P; Seyfert UT; Hellstern P
Br J Haematol; 2005 Sep; 130(5):759-67. PubMed ID: 16115134
[TBL] [Abstract][Full Text] [Related]
4. [Reconfirmation of preanalytical variables and establishment of reference intervals of platelet function analyzer-100 closure times in Korean adults].
Cho YU; Chi HS; Jang S; Park CJ
Korean J Lab Med; 2007 Oct; 27(5):318-23. PubMed ID: 18094595
[TBL] [Abstract][Full Text] [Related]
5. Comparison of nine platelet function tests used to determine responses to different aspirin dosages in people with type 2 diabetes.
Harrison P; Bethel MA; Kennedy I; Dinsdale R; Coleman R; Holman RR
Platelets; 2019; 30(4):521-529. PubMed ID: 29985735
[TBL] [Abstract][Full Text] [Related]
6. Variables that affect platelet function analyzer-100 (PFA-100) closure times and establishment of reference intervals in Korean adults.
Cho YU; Jang S; Park CJ; Chi HS
Ann Clin Lab Sci; 2008; 38(3):247-53. PubMed ID: 18715853
[TBL] [Abstract][Full Text] [Related]
7. Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100.
Roller RE; Dorr A; Ulrich S; Pilger E
Blood Coagul Fibrinolysis; 2002 Jun; 13(4):277-81. PubMed ID: 12032391
[TBL] [Abstract][Full Text] [Related]
8. PFA-100 system: a new method for assessment of platelet dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
[TBL] [Abstract][Full Text] [Related]
9. Platelet dysfunction detected at high shear in patients with heart valve disease.
Francis JL
Platelets; 2000 May; 11(3):133-6. PubMed ID: 10938889
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of the INNOVANCE PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y₁₂ receptor for adenosine diphosphate.
Scavone M; Germanovich K; Femia EA; Cattaneo M
Thromb Res; 2014 Feb; 133(2):254-6. PubMed ID: 24331208
[TBL] [Abstract][Full Text] [Related]
11. PFA-100 System: A New Method for Assessment of Platelet Dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 2024 Jun; 50(4):664-671. PubMed ID: 38092024
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
[TBL] [Abstract][Full Text] [Related]
13. In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor.
Chakroun T; Gerotziafas G; Robert F; Lecrubier C; Samama MM; Hatmi M; Elalamy I
Br J Haematol; 2004 Jan; 124(1):80-5. PubMed ID: 14675411
[TBL] [Abstract][Full Text] [Related]
14. Establishment of reference intervals for Platelet Function Analyzer -100 closure time in Algerian adults.
Belkacemi M; Merad Y; Merbouh MA
PLoS One; 2021; 16(4):e0249402. PubMed ID: 33844690
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients.
Kotzailias N; Elwischger K; Sycha T; Rinner W; Quehenberger P; Auff E; Müller C
J Stroke Cerebrovasc Dis; 2007; 16(5):199-202. PubMed ID: 17845916
[TBL] [Abstract][Full Text] [Related]
16. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.
Ortel TL; James AH; Thames EH; Moore KD; Greenberg CS
Thromb Haemost; 2000 Jul; 84(1):93-7. PubMed ID: 10928477
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the new INNOVANCE® PFA P2Y cartridge in patients with impaired primary haemostasis.
Koessler J; Ehrenschwender M; Kobsar A; Brunner K
Platelets; 2012; 23(8):571-8. PubMed ID: 22185369
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: a 6 months prospective study.
Gianetti J; Parri MS; Sbrana S; Paoli F; Maffei S; Paradossi U; Berti S; Clerico A; Biagini A
Thromb Res; 2006; 118(4):487-93. PubMed ID: 16343603
[TBL] [Abstract][Full Text] [Related]
19. Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals.
Seyfert UT; Haubelt H; Vogt A; Hellstern P
Platelets; 2007 May; 18(3):199-206. PubMed ID: 17497431
[TBL] [Abstract][Full Text] [Related]
20. Investigation of diagnostic importance of platelet closure times measured by Platelet Function Analyzer--PFA 100 in dogs with endotoxemia.
Yilmaz Z; Ilcol YO; Ulus IH
Berl Munch Tierarztl Wochenschr; 2005; 118(7-8):341-8. PubMed ID: 16048047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
